Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shaozhang Zhou, Huilin Wang, Wei Jiang & Qitao Yu. (2019) Clinicopathological Characteristics And EGFR-TKIs Efficacies In Lung Squamous Cell Carcinoma Patients Harboring An EGFR Sensitizing Mutation. OncoTargets and Therapy 12, pages 8863-8871.
Read now
Read now
Chao Zhang, Haitang Yang, Baoping Lang, Xiangdong Yu, Peng Xiao, Dian Zhang, Liwen Fan & Xiao Zhang. (2018) Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma. Cancer Management and Research 10, pages 2401-2407.
Read now
Read now
Articles from other publishers (3)
Ahmed Z. El-Hashim, Maitham A. Khajah, Rhema S. Babyson, Waleed M. Renno, Charles I. Ezeamuzie, Ibrahim F. Benter & Saghir Akhtar. (2019) Ang-(1-7)/ MAS1 receptor axis inhibits allergic airway inflammation via blockade of Src-mediated EGFR transactivation in a murine model of asthma. PLOS ONE 14:11, pages e0224163.
Crossref
Crossref
Masahiro Yamasaki, Kunihiko Funaishi, Wakako Daido & Noboru Hattori. (2019) Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib. Archivos de Bronconeumología 55:11, pages 602-603.
Crossref
Crossref
Masahiro Yamasaki, Kunihiko Funaishi, Wakako Daido & Noboru Hattori. (2019) Acquired T790M-positive Squamous Cell Lung Carcinoma that Responded to Osimertinib. Archivos de Bronconeumología (English Edition) 55:11, pages 602-603.
Crossref
Crossref